Myeloid Leukemia

WT1 Expression in AML and MDS 211
11. Sekiya, M., Adachi, M., Hinoda, Y., Imai, K., and Yachi, A. (1994)
Downregulation of the Wilms’ tumor gene (wt1) during myelomonocytic differentiation
in HL60 cells. Blood 83, 1876–1882.
12. Maurer, U., Brieger, J., Weidmann, E., Mitrou, P. S., Hoelzer, D., and Bergmann,
L. (1997) The Wilms’ tumor gene is expressed in a subset of CD34+ progenitors
and downregulated early in the course of differentiation in vitro. Exp. Hematol.
25, 945–950.
13. Cilloni, D. and Saglio, G. (2003) Usefulness of quantitative assessment of Wilms
Tumor gene expression in chronic myeloid leukemia patients undergoing imatinib
therapy. Semin. Hematol. 40, 37–41.
14. Cilloni, D., Gottardi, E., Fava, M., et al. (2003) Usefulness of quantitative assessment
of WT1 gene transcript as a marker for minimal residual disease detection.
Blood 15, 773–774.